Skip to main content

Advertisement

Table 1 Baseline patient characteristics, N = 35, TMZ - temozolomide.

From: MiRNA expression patterns predict survival in glioblastoma

Characteristic Patients
MGMT methylation status  
   • methylated 17
   • not methylated 13
   • unknown 5
Median follow-up (range) 530 days (16 - 1545)
Sex  
   • male 22
   • female 13
Median age (range) 62 (33 - 77)
Age  
   • < 60 y 14
   • ≥ 60 y 21
Type of resection  
   • complete 18
   • incomplete 17
RPA class  
   • III 4
   • IV 11
   • V 12
   • not exactly known 8
Re-RT  
   • yes 4
   • no 31
Concomitant TMZ  
   • yes 26
   • no 7
   • unknown 2
Adjuvant TMZ  
   • yes 19
   • no 14
   • unknown 2
Survival  
   • long-term 20
   • short-term 15